Immediate Impact

43 standout
Sub-graph 1 of 21

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
2025 Standout
2 intermediate papers

Works of Takuya Haraguchi being referenced

Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study
2021
Sodium‐glucose co‐transporter‐2 inhibitor use and dietary carbohydrate intake in J apanese individuals with type 2 diabetes: A randomized, open‐label, 3‐arm parallel comparative, exploratory study
2016

Author Peers

Author Last Decade Papers Cites
Takuya Haraguchi 96 43 11 34 8 131
Giuseppe Favacchio 101 29 14 35 9 160
Xiafei Lyu 49 56 16 35 6 127
R.-M. Schmülling 102 29 27 55 10 223
Noémie Dubois 55 54 19 26 8 175
Naina Sinha Gregory 67 38 9 33 11 185
Philip Newland‐Jones 137 45 19 44 9 206
Takeshi Arishima 180 44 12 21 9 237
Max Miller 27 27 21 41 10 189
Sharon Kean 42 42 36 16 8 185
Patrizia Ippolita Patera 91 78 7 32 10 183

All Works

Loading papers...

Rankless by CCL
2026